TEM-121, a Novel Complex Mutant of TEM-Type β-Lactamase from Enterobacter aerogenes

ABSTRACT Enterobacter aerogenes clinical isolate LOR was resistant to penicillins and ceftazidime but susceptible to cefuroxime, cephalothin, cefoxitin, cefotaxime, ceftriaxone, and cefepime. PCR and cloning experiments from this strain identified a novel TEM-type β-lactamase (TEM-121) differing by five amino acid substitutions from β-lactamase TEM-2 (Glu104Lys, Arg164Ser, Ala237Thr, Glu240Lys, and Arg244Ser) and by only one amino acid change from the extended-spectrum β-lactamase (ESBL) TEM-24 (Arg244Ser), with the last substitution also being identified in the inhibitor-resistant β-lactamase IRT-2. Kinetic parameters indicated that TEM-121 hydrolyzed ceftazidime and aztreonam (like TEM-24) and was inhibited weakly by clavulanic acid and strongly by tazobactam. Thus, TEM-121 is a novel complex mutant TEM β-lactamase (CMT-4) combining the kinetic properties of an ESBL and an inhibitor-resistant TEM enzyme.

[1]  R. Venezia,et al.  Nucleotide Sequence of the ChromosomalampC Gene of Enterobacter aerogenes , 2000, Antimicrobial Agents and Chemotherapy.

[2]  P. Nordmann,et al.  Molecular and Biochemical Heterogeneity of Class B Carbapenem-Hydrolyzing β-Lactamases in Chryseobacterium meningosepticum , 2000, Antimicrobial Agents and Chemotherapy.

[3]  W. Hryniewicz,et al.  A Novel Complex Mutant β-Lactamase, TEM-68, Identified in a Klebsiella pneumoniae Isolate from an Outbreak of Extended-Spectrum β-Lactamase-Producing Klebsiellae , 2000, Antimicrobial Agents and Chemotherapy.

[4]  V. Jarlier,et al.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. , 1988, Reviews of infectious diseases.

[5]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[6]  M. Gazouli,et al.  Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant , 1997, Antimicrobial agents and chemotherapy.

[7]  R. Bonnet,et al.  TEM Derivative-Producing Enterobacter aerogenes Strains: Dissemination of a Prevalent Clone , 2002, Antimicrobial Agents and Chemotherapy.

[8]  R. Cluzel,et al.  Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 beta-lactamase genes , 1992, Antimicrobial Agents and Chemotherapy.

[9]  P. Courvalin,et al.  TEM-103/IRT-28 β-Lactamase, a New TEM Variant Produced by Escherichia coli BM4511 , 2002, Antimicrobial Agents and Chemotherapy.

[10]  T J Dougherty,et al.  Substitution of lysine at position 104 or 240 of TEM-1pTZ18R beta-lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam. , 1991, Biochemistry.

[11]  R. Bonomo,et al.  Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases. , 1997, FEMS microbiology letters.

[12]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[13]  A. Péchinot,et al.  TEM-89 β-Lactamase Produced by a Proteus mirabilis Clinical Isolate: New Complex Mutant (CMT 3) with Mutations in both TEM-59 (IRT-17) and TEM-3 , 2001, Antimicrobial Agents and Chemotherapy.

[14]  G. Paul,et al.  Catalytic and structural properties of IRT-21 beta-lactamase (TEM-77) from a co-amoxiclav-resistant Proteus mirabilis isolate. , 2001, FEMS microbiology letters.

[15]  P. Nordmann,et al.  Outbreak of Extended-Spectrum β-Lactamase VEB-1-Producing Isolates of Acinetobacter baumannii in a French Hospital , 2003, Journal of Clinical Microbiology.

[16]  J M Ghuysen,et al.  A standard numbering scheme for the class A beta-lactamases. , 1991, The Biochemical journal.

[17]  G. Paul,et al.  Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics. , 1999, The Journal of antimicrobial chemotherapy.

[18]  J. Knox,et al.  Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure , 1995, Antimicrobial agents and chemotherapy.

[19]  C. Quentin,et al.  Molecular Characterization of TEM-59 (IRT-17), a Novel Inhibitor-Resistant TEM-Derived β-Lactamase in a Clinical Isolate of Klebsiella oxytoca , 1999, Antimicrobial Agents and Chemotherapy.

[20]  M Ikehara,et al.  Essential structure of E. coli promoter: effect of spacer length between the two consensus sequences on promoter function. , 1983, Nucleic acids research.

[21]  S. Castelain,et al.  Coexistence of SHV-4- and TEM-24-Producing Enterobacter aerogenes Strains before a Large Outbreak of TEM-24-Producing Strains in a French Hospital , 2001, Journal of Clinical Microbiology.

[22]  J. Pagés,et al.  Most Enterobacter aerogenes Strains in France Belong to a Prevalent Clone , 1999, Journal of Clinical Microbiology.

[23]  C. Recule,et al.  A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate , 1997, Antimicrobial agents and chemotherapy.